InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by BLUTT MITCHELL J MD, Director. Officer active across 2 companies, notably Consonance-HFW Acquisition Corp.. Aggregated, 7 reports have been recorded. Split: 0 buy · 1 sell. History available since 4 September 2020. The latest transaction was filed on 4 September 2020 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations7 total
1,748,750 sharesCommon StockSEC:0000899243-22-038571:0
500,000 sharesClass A Ordinary SharesSEC:0000899243-21-033025
500,000 sharesClass A Ordinary SharesSEC:0000899243-21-033025:0
3,593,750 shares@ US$0.00750.0% of flowClass B Ordinary SharesSEC:0000899243-21-019995
3,593,750 shares@ US$0.00750.0% of flowClass B Ordinary SharesSEC:0000899243-21-019995:0
24,000 sharesClass A Ordinary SharesSEC:0000899243-21-019983
24,000 sharesClass A Ordinary SharesSEC:0000899243-21-019983:0
7 of 7 declarations
About BLUTT MITCHELL J MD
Mitchell J. Blutt, MD, is a Director of Consonance-HFW Acquisition Corp. and Surrozen, Inc./DE. He brings his medical and strategic expertise to the board, contributing to the direction of the companies.
